The adoption of the Ex-Pharm Series is supported by several major regulatory bodies in India: National Medical Commission (NMC)
: By using simulations, institutions adhere to "3Rs" (Replacement, Reduction, and Refinement) guidelines, sparing thousands of animals while maintaining academic rigor. xpharm series software
: Study the dose-response curve (DRC) and the impact of various chemical mediators. The adoption of the Ex-Pharm Series is supported